Protective Effect of Erythropoietin and Its Carbamylated Derivative in Experimental Cisplatin Peripheral Neurotoxicity
Roberto Bianchi(AOL (United States)), Guido Cavaletti(Bellvitge University Hospital), Anthony Cerami(Araim Pharmaceuticals (United States)), Michael Brines(Northwell Health), A Canta(University of Milano-Bicocca), Costanza Savino(University of Messina), Paola Penza, Giuseppe Lauria(University of Milan), A. Ronchi(Fondazione Salvatore Maugeri), Pietro Ghezzi(Brighton and Sussex Medical School), Alessandra Gilardini(University of Milano-Bicocca), Gabriella Nicolini(University of Milano-Bicocca), N Oggioni(University of Milano-Bicocca), Raffaella Lombardi(Apple (Israel)), Claudio Minoia(Fondazione Salvatore Maugeri), Virginia Rodriguez‐Menendez(University of Milano-Bicocca)
Cited by 92
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k